Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in IMUX — Immunic, Inc.

CIK 1603466 STAMFORD, CT
Back to IMUX Full portfolio

Position in IMUX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$166,088
-$898,747 QoQ
Shares Held
10,806
-84.9% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 55 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. IMUX ranks #144 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in IMUX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $166,088 10,806
2023-03-31 $1,064,835 714,655
2022-12-31 $1,000,517 714,655
2022-09-30 $4,187,000 1,325,000
2022-06-30 $4,597,750 1,325,000
2022-03-31 $8,192,500 725,000
2021-12-31 $6,938,250 725,000
2021-09-30 $5,531,250 625,000
2021-03-31 $6,902,769 433,047
2020-12-31 $3,126,805 204,500
2020-06-30 $2,121,000 175,000